Postmenopausal hormone replacement therapy for primary prevention of cardiovascular and cerebrovascular disease: Recommendation statement from the Canadian Task Force on Preventive Health Care

This publication has 30 references indexed in Scilit:

• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis
  New England Journal of Medicine, 2000
• Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
  JAMA, 1998
• Cause-Specific Mortality in Women Receiving Hormone Replacement Therapy
  Epidemiology, 1997
• Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease
  New England Journal of Medicine, 1996
• EVIDENCE OF A HEALTHY ESTROGEN USER SURVIVOR EFFECT
  Epidemiology, 1995
• The risk of acute myocardial infarction after oestrogen and oestrogen‐progestogen replacement
  BJOG: An International Journal of Obstetrics and Gynaecology, 1992
• Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
  Preventive Medicine, 1991
• Use of Replacement Estrogens and the Risk of Myocardial Infarction
  Epidemiology, 1990
• Postmenopausal Estrogen Use, Cigarette Smoking, and Cardiovascular Morbidity in Women over 50
  New England Journal of Medicine, 1985